Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Warning on Faulty Implanted Defibrillators

By HospiMedica staff writers
Posted on 29 Jun 2005
Certain implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices develop an internal short circuit without warning, resulting in failure to deliver a shock when needed. More...
The manufacturer, Guidant Corp. (Indianapolis, IN, USA), is advising doctors worldwide of this development so they can decide how best to treat their patients.

The devices involved are the Ventak Prizm 2DR (model 1861) ICDs manufactured on or before April 16, 2002; the Contak Renewal (model H135) and Contak Renewal 2 (model H155), manufactured on or before August 26, 2004; and the Ventak Prizm AVT, Vitality AVT, Renewal 3AVT, and Renewal 4 AVT ICSs (all series).

The Prizm 2 and Renewal devices are subject to failures that result in the inability to deliver an electric shock during episodes of arrhythmia, which could lead to a serious, life-threatening event for a patient. Twenty-eight reports of failure have been reported worldwide in the Ventak Prizm 2 DR devices, including one death. Fifteen reports of failure mode have been confirmed in the Contak Renewal devices. Two deaths suspected to be associated with this malfunction have been reported to the U.S. Food and Drug Administration (FDA, Washington, DC, USA; www.fda.gov). Guidant recommends that doctors of patients with these devices should continue with normal follow-up visits at three-month intervals. If a decision is made to replace a device, Guidant will provide a replacement at no charge.

In addition, the company's Ventak Prizm AVT, Vitality AVT, Renewal 3 AVT, and Renewal 4 AVT devices are subject to a memory error, which may affect available therapy. Guidant is recommending a programming change that can reduce the risk of this happening, a change that can be implemented at the next office visit a patient makes.

The FDA is considering this action of Guidant as a recall and is not making any recommendations at this time on whether individual patients who have one of the devices should have it removed and replaced. That is a decision that should be made by patients in consultation with their doctors. If patients feel an electrical shock from their device or hear an audible "beeping,” they should immediately contact their doctor.




Related Links:
Guidant

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.